Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

7 treatments under study, led by Standard Of Care

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
P 2 (1)

Trial Status

Completed2
Recruiting1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Standard Of Care2
  • Direct Oral Penicillin Challenge1
  • Calcium Dobesilate Doxium1
  • Direct Oral Challenge1
  • Tranexamic Acid1

Active Sponsors

  • University Of Nove De Julho1
  • District Headquarters Teaching Hospital Sahiwal1
  • Deniz Göcebe1
  • Austin Health1

Related Conditions

  • Hypersensitivity Immediate3
  • Hypersensitivity Delayed2
  • Agranulocytosis1
  • Bleeding Pattern1
  • Bleeding1

Activity Timeline